Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
4.9M
-
Shares change
-
+231K
-
Total reported value, excl. options
-
$17.4M
-
Value change
-
+$818K
-
Number of buys
-
5
-
Number of sells
-
-1
-
Price
-
$3.54
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2017
17 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2017.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.9M shares
of 108M outstanding shares and own 4.56% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.16M shares), Southpoint Capital Advisors LP (792K shares), Knoll Capital Management, LP (462K shares), VANGUARD GROUP INC (205K shares), GEODE CAPITAL MANAGEMENT, LLC (101K shares), MORGAN STANLEY (58.9K shares), Bank of New York Mellon Corp (30.4K shares), NORTHERN TRUST CORP (22.7K shares), GARRISON BRADFORD & ASSOCIATES INC (15.5K shares), and ROYAL BANK OF CANADA (14K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.